A detailed history of Uma Financial Services, Inc. transactions in Exelixis, Inc. stock. As of the latest transaction made, Uma Financial Services, Inc. holds 40 shares of EXEL stock, worth $1,666. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40
Previous 46 13.04%
Holding current value
$1,666
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 04, 2025

SELL
$36.22 - $46.25 $217 - $277
-6 Reduced 13.04%
40 $1,000
Q2 2025

Jul 11, 2025

BUY
$34.13 - $46.26 $955 - $1,295
28 Added 155.56%
46 $2,000
Q1 2025

Apr 28, 2025

BUY
$32.38 - $39.16 $582 - $704
18 New
18 $0

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $13.4B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Uma Financial Services, Inc. Portfolio

Follow Uma Financial Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Uma Financial Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Uma Financial Services, Inc. with notifications on news.